Molecular Analysis of Alliance A031201 Study

Request Access

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

M. Morris, G. Heller, D. Hillman, et al.. (2023). Journal of Clinical Oncology. Cited 20 times. https://doi.org/10.1200/JCO.22.02394
NCPI Dataset Catalog
Feedback & Support
v0.10.0-b29ba7e